Diabetic Ketoacidosis

Detailed Overview

DKA results from an absolute or relative deficiency of insulin combined with an excess of counterregulatory hormones (glucagon, catecholamines, cortisol, growth hormone). This hormonal imbalance shifts metabolism from glucose utilization to uncontrolled lipolysis and fatty acid oxidation, generating massive amounts of ketone bodies (acetoacetate and beta-hydroxybutyrate). The resulting osmotic diuresis causes profound volume depletion and electrolyte derangement.

Epidemiology & Demographics

Annual incidence in patients with type 1 diabetes is 4-8 episodes per 1000 patients. Most common in young adults (<30 years old). Mortality is <1% in specialized centers but higher in the elderly or those with severe comorbidities.

Etiological Mechanism

Precipitated by events that increase insulin requirements or interrupt insulin delivery. Non-adherence to insulin therapy is the most common cause in younger patients. Infection is the most common physiological trigger.

Primary Causes

Infection (pneumonia, UTI), omission or inadequate administration of insulin, myocardial infarction, acute pancreatitis, medications (SGLT2 inhibitors, corticosteroids, atypical antipsychotics).

• Insulin omission: Psychological issues, eating disorders, or financial inability to afford insulin.
• Intercurrent illness: Any acute physiological stress like sepsis or surgery.
• SGLT2 inhibitor use: Risk for euglycemic DKA (DKA with blood glucose <250 mg/dL).

Insulin deficiency allows unchecked glucagon action, activating hepatic gluconeogenesis and glycogenolysis, driving serum glucose >250 mg/dL. Simultaneously, hormone-sensitive lipase in adipose tissue is disinhibited, causing massive release of free fatty acids (FFAs). In the liver, FFAs are beta-oxidized into acetyl-CoA. Without insulin, acetyl-CoA is shunted into ketogenesis, producing beta-hydroxybutyrate and acetoacetate. These acidic ketone bodies consume bicarbonate buffering capacity, generating a high anion gap metabolic acidosis. Hyperglycemia induces an osmotic diuresis, leading to the loss of water (up to 5-8 liters), sodium, potassium, and phosphorus.

Characteristic Clinical Presentation

• Polyuria and Polydipsia: Excessive urination and thirst due to profound osmotic diuresis.
• Nausea and Vomiting: Severe GI upset due to ketosis and acidosis.
• Abdominal pain: Can mimic an acute abdomen, more common in children.
• Altered mental status: Ranging from mild lethargy to deep coma due to hyperosmolality and severe acidosis.

Physical Examination Signs

• Kussmaul respirations (deep, rapid breathing to blow off CO2).
• Fruity odor to breath (due to exhaled acetone).
• Tachycardia and hypotension (signs of volume depletion).
• Decreased skin turgor and dry mucous membranes.

• Cerebral edema: Usually in children, caused by rapid fluid shifts and osmolality drops during treatment. High mortality.
• Severe Hypokalemia: Insulin treatment drives potassium intracellularly, which can cause fatal arrhythmias if not repleted.
• Acute Respiratory Distress Syndrome (ARDS): Due to fluid overload during aggressive resuscitation.

Diagnostic Criteria & Guidelines

Blood glucose > 250 mg/dL (except in euglycemic DKA), positive serum/urine ketones (specifically beta-hydroxybutyrate), arterial pH < 7.30, serum bicarbonate < 18 mEq/L, and high anion gap (> 10-12 mEq/L).

Differential Diagnosis

• Hyperosmolar Hyperglycemic State (HHS)
• Alcoholic ketoacidosis
• Starvation ketosis
• High anion gap acidosis from toxic alcohols, lactic acidosis, or renal failure

Laboratory Tests & Biomarkers

• Serum Beta-Hydroxybutyrate: > 3.0 mmol/L (indicates ketonemia).
• Basic Metabolic Panel: Glucose > 250 mg/dL, Bicarbonate < 18 mEq/L, Anion gap > 12.
• Serum Potassium: Often falsely normal or high (e.g., 5.5 mEq/L) due to extracellular shift, despite massive total body potassium deficit (3-5 mEq/kg).

Imaging Modalities & Findings

• Chest X-ray: Obtained to rule out pneumonia as an infectious trigger.
• Head CT: Indicated if altered mental status persists or deteriorates (to rule out cerebral edema).

• Mild
  Arterial pH 7.25-7.30, bicarb 15-18 mEq/L, patient is alert.
• Moderate
  Arterial pH 7.00-7.24, bicarb 10-<15 mEq/L, patient is alert/drowsy.
• Severe
  Arterial pH <7.00, bicarb <10 mEq/L, patient is stuporous or comatose.

Second-Line & Adjunctive Therapy

Transition to subcutaneous basal-bolus insulin once DKA is resolved (anion gap < 12, bicarb > 15, patient able to eat). Overlap IV insulin and SQ insulin by 1-2 hours to prevent rebound ketosis.

Surgical & Procedural Management

N/A for DKA itself. Surgical management applies only to triggering causes (e.g., debridement of necrotizing fasciitis, cholecystectomy).

Recommended Lifestyle Changes

• Frequent blood glucose monitoring (at least 4 times daily).
• Check urine or blood ketones when blood glucose > 250 mg/dL or feeling unwell.

Patient Counseling & Advice

Educate on Sick Day Management rules: never stop taking insulin even if vomiting; increase fluid intake; monitor glucose every 2-4 hours; contact provider if vomiting persists or ketones are moderate/large.

Follow-Up & Monitoring Schedule

In hospital: hourly blood glucose; basic metabolic panel every 2-4 hours until anion gap closes. Outpatient: follow-up with endocrinologist within 1-2 weeks of discharge to adjust insulin regimen.

Preventive Strategies

Diabetes education regarding insulin adherence and use of continuous glucose monitors (CGM). Prompt management of acute infections.

Overall mortality is <1% with proper management, primarily driven by underlying precipitating illness (like MI or sepsis) or complications like cerebral edema.